Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

Abstract Background The last decade was marked by major advances in HCV treatment with the introduction of first wave protease inhibitors (1st-wave PIs, telaprevir or boceprevir) in 2011 and second direct-acting antivirals (2nd-wave DAAs) in 2014, that followed low effective pegylated interferon α /...

Full description

Bibliographic Details
Main Authors: Cécile Brouard, Marjorie Boussac-Zarebska, Christine Silvain, Julien Durand, Victor de Lédinghen, Josiane Pillonel, Elisabeth Delarocque-Astagneau
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis C
Treatment
Direct-acting antivirals
Health insurance data
Epidemiology
France
Online Access:http://link.springer.com/article/10.1186/s12879-017-2889-4

Internet

http://link.springer.com/article/10.1186/s12879-017-2889-4

Similar Items